[Translated article] Pharmaceutical care in respiratory diseases: Current situation and opportunities for hospital pharmacy in Spain.

OBJECTIVE: Respiratory diseases present a challenge for the healthcare system due to their prevalence and clinical impact. The aim of this study was to explore the current situation of hospital pharmacy in the field of respiratory diseases. METHOD: Observational, cross-sectional study, with a national scope, divided into 2 parts. In an initial phase, the activity and level of pharmaceutical care in respiratory diseases was evaluated through an online questionnaire using REDCap. The survey was addressed to department chiefs and consisted of 17 items, divided into 2 modules: general data and general activity. The second phase was open to hospital pharmacists, with the aim of exploring their opinion on care, training, and improvement needs. The number of items in this phase was 19, divided into 5 modules: general data, pharmaceutical care, competencies, training, and degree of satisfaction. RESULTS: In the first phase, 23 hospitals were included. Most of them (n=20) had a pharmacist in charge of respiratory diseases. However, a large proportion of them dedicated less than 40% of their working day to this activity. The pharmacist's activity occurred at the level of external patients (n=21), hospitalised patients (n=16), and secondarily in management (n=8). Integration is greater in pathologies such as asthma, IPF, pulmonary hypertension, and bronchiectasis. Participation in committees was present in 15 hospitals, with variability in pathologies and degree of involvement. In the second phase, 164 pharmacists participated, who considered pharmaceutical care in cystic fibrosis, asthma, and lung transplant as a priority. 51% considered integration to be adequate and 91% considered it necessary to implement prioritisation criteria. Professional competencies ranged from 6.5 to 6.9 out of 10 points. Only 45% of participants had received specific training in the last 4 years, indicating greater priority for asthma, pulmonary hypertension, and IPF. CONCLUSIONS: Most centers have pharmacists specialised in respiratory diseases. However, there is room for improvement in terms of subspecialisation, participation in multidisciplinary committees, implementation of prioritisation criteria, diversification in pathologies treated, as well as greater specific training in this area.

Pharmaceutical care in respiratory diseases: Current situation and opportunities for Hospital Pharmacy in Spain. / Atención farmacéutica en enfermedades respiratorias: situación y oportunidades de la farmacia hospitalaria en España.

OBJECTIVE: Respiratory diseases present a challenge for the healthcare system due to their prevalence and clinical impact. The aim of this study was to explore the current situation of hospital pharmacy in the field of respiratory diseases. METHOD: Observational, cross-sectional study, with a national scope, divided into 2 parts. In an initial phase, the activity and level of pharmaceutical care in respiratory diseases was evaluated through an online questionnaire using REDCap. The survey was addressed to department chiefs and consisted of 17 items, divided into 2 modules: general data and general activity. The second phase was open to hospital pharmacists, with the aim of exploring their opinion on care, training, and improvement needs. The number of items in this phase was 19, divided into 5 modules: general data, pharmaceutical care, competencies, training and degree of satisfaction. RESULTS: In the first phase, 23 hospitals were included. Most of them (n=20) had a pharmacist in charge of respiratory diseases. However, a large proportion of them dedicated less than 40% of their working day to this activity. The pharmacist's activity occurred at the level of external patients (n=20), hospitalized patients (n=16), and secondarily in management (n=8). Integration is greater in pathologies such as asthma, IPF, pulmonary hypertension, and bronchiectasis. Participation in committees was present in 15 hospitals, with variability in pathologies and degree of involvement. In the second phase, 164 pharmacists participated, who considered pharmaceutical care in cystic fibrosis, asthma and lung transplant as a priority. Fifty-one percent considered integration to be adequate and 91% considered it necessary to implement prioritization criteria. Professional competencies ranged from 6.5-6.9 out of 10 points. Only 45% of participants had received specific training in the last four years, indicating greater priority for asthma, pulmonary hypertension and IPF. CONCLUSIONS: Most centers have pharmacists specialized in respiratory diseases. However, there is room for improvement in terms of sub specialization, participation in multidisciplinary committees, implementation of prioritization criteria, diversification in pathologies treated, as well as greater specific training in this area.

Valores de referencia de espirometría forzada de adultos residentes sobre o bajo 1500 m s. n. m.: revisión sistemática / Reference values of forced spirometry of adult residents above or below 1500 m.a.s.l.: systematic review

Introducción: La espirometría es una prueba de función pulmonar usada en la valoración de programas de rehabilitación para evaluar exposiciones a tóxicos y alérgenos, en estudios epidemiológicos y en el desarrollo de ecuaciones de referencia en poblaciones específicas; estos valores pueden variar de acuerdo con la altura. Objetivo: Establecer las diferencias entre los valores de referencia de espirometría forzada en población adulta residentes en alturas mayores y menores a 1500 metros sobre el nivel del mar. Métodos: Revisión sistemática, se encontraron 536 estudios, se evaluaron 66 en texto completo, 33 en calidad metodológica con las listas de chequeo Quality Assessment Tool for Observational Cohort and Cross-Sectional Studies y Quality Assessment of Case-Control Studies; 21 estudios fueron seleccionados para la revisión y 12 surtieron metanálisis. Resultados: Se contó con 48 923 participantes de alturas entre 2,4 y 4440 m s. n. m. Hay diferencias iniciales al relacionar la altura (+/-1500 m s. n. m) con el VEF1 (hombres: DM 0,29; IC: 0,03-0,55; mujeres: DM 0,27; IC: -0,07-0,60) y los valores de referencia con el sexo: CVF (DM 1,31; IC: 1,24-1,37) y VEF1 (DM: 1,03; IC: 0,95-1,11). Se reportó alta heterogeneidad y riesgo de sesgo de publicación. Discusión: Estas diferencias se dan en función de aspectos antropométricos y fisiológicos como la aclimatación y el envejecimiento pulmonar. Los mecanismos que influyen en estos cambios son la adaptación genética, molecular, fisiológica y anatómica, que permiten compensar los efectos de la hipoxia aguda o crónica, lo cual aumenta la ventilación alveolar y los valores espirométricos. Conclusiones: Los valores de referencia de espirometría varían de acuerdo con la altura (mayores en alturas > 1500 m s. n. m) y el sexo (más elevados en hombres). Es necesario contar con evidencias más amplias y contundentes en la temática.

Introduction: Spirometry is a lung function test used in the evaluation of rehabilitation programs to evaluate exposures to toxics and allergens in epidemiological studies and in the development of reference equations in specific populations; these values may vary according to height. Objective: To establish the differences between the reference values of forced spirometry in the adult population living at altitudes greater than and less than 1,500 meters above sea level. Methods: Systematic review a total of 536 studies were found; 66 were assessed in full text and 33 were assessed for methodological quality using the Quality Assessment Tool for Observational Cohort and Cross-Sectional Studies and Quality Assessment of Case-Control Studies checklists; 21 studies were selected for the review and 12 provided meta-analyses. Results: There were 48,923 participants from heights between 2.4 and 4,440 m.a.s.l. There are initial differences when relating height (+/-1,500 m.a.s.l.) with FEV1 (men: MD 0.29; CI: 0.03-0.55; women: MD 0.27; CI: -0.07-0 .60); and the reference values with gender: FVC (MD 1.31, CI: 1.24-1.37) and FEV1 (MD: 1.03, CI: 0.95-1.11). High heterogeneity and risk of publication bias are reported. Discussion: These differences occur based on anthropometric and physiological aspects such as acclimatization and lung aging. The mechanisms that influence these changes are genetic, molecular, physiological and anatomical adaptations that allow compensation for the effects of acute or chronic hypoxia, which increases alveolar ventilation and spirometric values. Conclusions: The spirometry reference values vary according to height (higher at heights >1,500 m.a.s.l.) and sex (higher in men). It is necessary to have broader and more convincing evidence on the subject.

Caracterización de pacientes con cáncer de pulmón en un servicio de neumología / Characterization of patients with lung cancer in a pneumology service i: en

Introducción: El cáncer de pulmón es un problema de salud pública a escala mundial y Cuba no está exenta de este. Objetivo: Caracterizar a los pacientes diagnosticados con cáncer de pulmón según variables clínicas, epidemiológicas y morfológicas. Métodos: Se realizó un estudio transversal, descriptivo y retrospectivo de los 145 adultos diagnosticados con cáncer de pulmón en el Servicio de Neumología del Hospital General Docente Dr. Juan Bruno Zayas Alfonso de Santiago de Cuba, desde enero del 2018 hasta diciembre del 2019. A tal efecto, en el procesamiento estadístico se emplearon como medidas de resumen el porcentaje y la media para variables cualitativas y cuantitativas, respectivamente; asimismo, se aplicaron el coeficiente kappa para establecer el grado de concordancia entre datos y la prueba de independencia de la Χ2 para identificar asociación significativa entre los criterios de interés seleccionados (con p<0,05). Resultados: Se obtuvo un predominio del sexo masculino (62,1 %) y el grupo etario de 65-75 años (37,9 %). Respecto a la variedad histológica, resultó más frecuente el carcinoma epidermoide (42,7 %). El pulmón derecho fue el más afectado, específicamente su lóbulo superior (33,8 %); del mismo modo, existieron alteraciones morfológicas, como la infiltración bronquial (100,0 %), la irregularidad y el edema de la mucosa (con 98,5 % en cada caso) y la inflamación con engrosamiento de la pared bronquial (90,3 %). Conclusiones: La determinación de las características clínicas, epidemiológicas y morfológicas relacionadas con el cáncer de pulmón permite efectuar el correcto seguimiento de los pacientes y aplicar un adecuado protocolo terapéutico.

Introduction: Lung cancer is a public health problem worldwide and Cuba is not exempt from it. Objective: Characterize patients diagnosed with lung cancer according to clinical, epidemiological and morphological variables. Methods: A cross-sectional, descriptive and retrospective study was carried out on 145 adults diagnosed with lung cancer in the Pneumology Service of Dr. Juan Bruno Zayas Alfonso Teaching General Hospital in Santiago de Cuba, from January, 2018 to December, 2019. For this purpose, in the statistical processing, the percentage and mean were used as summary measures for qualitative and quantitative variables, respectively; Likewise, there were applied the kappa coefficient to establish the degree of agreement between data and the Χ2 independence test to identify a significant association between the selected criteria of interest (with p<0.05). Results: There was a predominance of the male sex (62.1%) and the age group of 65-75 years (37.9%). Regarding the histological type, squamous cell carcinoma was more common (42.7%). The right lung was the most affected, specifically its upper lobe (33.8%); also, there were morphological alterations, such as bronchial infiltration (100.0%), mucosal irregularity and edema (with 98.5% in each case), and inflammation with bronchial wall thickening (90.3%). Conclusions: The determination of the clinical, epidemiological and morphological characteristics related to lung cancer makes it possible to carry out the correct follow-up of the patients and apply an appropriate therapeutic protocol.

[Tezepelumab: a new option for the treatment of severe asthma]. / Tezepelumab: una nueva opción para el tratamiento del asma grave.

In Latin America, asthma is a public health problem with a significant impact on both patients and health systems. The greater understanding of the pathophysiology and the recognition of the central role that inflammation has in the severity of asthma has favored the development of monoclonal antibodies that have IL-5, IL-4, IL-13 and IgE as therapeutic targets. Although these therapeutic alternatives promote better control of the disease, not all patients respond favorably to these treatments. Therefore, it is of particular interest to explore monoclonal antibodies such as Tezepelumab, directed against thymic stromal lymphopoietin (TSLP), an alarmin (epithelial cytokine) that participates in the initiation and perpetuation of inflammation in Asthma. Therefore, in this review, we will show the clinical efficacy of tezepelumab in reducing the annual rate of exacerbations, improving lung function, and reducing bronchial hyperreactivity, regardless of the patient's baseline biomarker levels. Therefore, this new molecule is a highly effective therapeutic option for patients with severe asthma.

En Latinoamérica, el asma es un problema de salud pública con un impacto importante tanto para los pacientes como para los sistemas de salud. El mayor entendimiento de la fisiopatología y el reconocimiento del papel central que tiene la inflamación en la severidad del asma ha favorecido el desarrollo de anticuerpos monoclonales que tienen como blancos terapéuticos a la IL-5, IL-4, IL-13 y la IgE. Si bien estas alternativas terapéuticas favorecen un mejor control de la enfermedad, no todos los pacientes responden favorablemente a esos tratamientos. Por lo que resulta de particular interés explorar anticuerpos monoclonales como el Tezepelumab, dirigido contra la linfopoyetina estromal tímica (TSLP) una alarmina (citocina epitelial) que participa en el inicio y la perpetuación de la inflamación en el Asma. Por lo que, en esta revisión, mostraremos la eficacia clínica del tezepelumab en la disminución de la tasa anual de exacerbaciones, mejora en la función pulmonar y en la disminución en la hiperreactividad bronquial, independientemente de los niveles de biomarcadores basales que el paciente presente. Por lo que esta nueva molécula es una opción terapéutica altamente eficaz para el paciente con asma grave.

Neumonía lipoidea exógena y anorexia nerviosa: caso clínico / Exogenous lipoid pneumonia and anorexia nervosa: a case report

La neumonía lipoidea exógena es una entidad infrecuente y con una presentación clínica inespecífica. Su diagnóstico temprano es clave para prevenir la fibrosis pulmonar que produce su cronificación. Presentamos el proceso diagnóstico de una paciente de 51 años, con clínica de tos con expectoración amarillenta, sin síntomas de infección ni fiebre, de larga evolución. En latomografía axial computarizada se observaron infiltrados pulmonares bilaterales de tipo alveolar. Se realizó un lavado broncoalveolar en el que se obtuvo un material amarillento de origen desconocido, que no permitió alcanzar ninguna conclusión clara. La criobiopsia pulmonar fue la prueba clave que llevó al diagnóstico de neumonía lipoidea exógena, en probable relación con la anorexia con hábito purgativo que la paciente sufría de forma crónica. Hallado el origen del problema, la paciente se encuentra actualmente en proceso de recuperación y cambio de hábitos, sin tos ni expectoración.(AU)

Exogenous lipoid pneumonia is a rare entity with non-specific clinical presentation. Early diagnosis is key to prevent pulmonary fibrosis in cases of chronic exogenous lipoid pneumonia . Here, we present the diagnostic process in a 51-year-old female with chronic cough and yellow sputum, no fever nor signs of infection. The computerized axial tomography scan showed alveolar infiltrates in both lungs. We per-formed a bronchoalveolar lavage and collected a yellowish material, but no clear result were obtained from its analysis. Cryobiopsy of lung tissue was key for the diagnosis ofexogenous lipoid pneumonia . This may be related to the chronic anorexia nervosa that the patient suffers, associated with purgative habits. After identifying the cause of the symptoms, the patient is recovering, changing her habits, and has no cough nor sputum.(AU)

Health outcomes: Towards the accreditation of respiratory medicine departments / Resultados de salud: hacia la acreditación de los servicios de neumología

National health systems must ensure compliance with conditions such as equity, efficiency, quality, and transparency. Since it is the right of society to know the health outcomes of its healthcare system, our aim was to develop a proposal for the accreditation of respiratory medicine departments in terms of care, teaching, and research, measuring health outcomes using quality of care indicators. The management tools proposed in this article should be implemented to improve outcomes and help us achieve our objectives. Promoting accreditation can serve as a stimulus to improve clinical management and enable professionals to take on greater leadership roles and take action to improve outcomes in patient care. (AU)

Los sistemas nacionales de salud deben garantizar a los ciudadanos el cumplimiento de unas condiciones básicas como la equidad, la eficiencia, la calidad y la transparencia. En aras del derecho que tiene la sociedad a conocer los resultados de salud de su área sanitaria, el objetivo de este artículo es elaborar una propuesta de acreditación de los servicios de neumología desde el punto de vista asistencial, docente e investigador, midiendo sus resultados de salud a través de indicadores de calidad en la atención. Para mejorar estos, deberíamos utilizar unas herramientas de gestión (que se desarrollan en el artículo) y que, sin duda, nos ayudarían a conseguir los objetivos propuestos. La mejora del nivel de acreditación puede servir como estímulo para perfeccionar la gestión clínica y para que los profesionales ejerzan una capacidad de dirección cada vez mayor y adopten medidas para reforzar los resultados en la atención a sus pacientes. (AU)

Lactante con teratoma mediastinal y neumonitis asociada. Reporte de caso / Infant with mediastinal teratoma and associated pneumonitis: a case report

RESUMEN Introducción: el teratoma es un tumor que se origina de las células germinales y está constituido por diferentes tejidos derivados de una o de varias capas embrionarias. Los teratomas del mediastino surgen como consecuencia de un error embriogénico durante la migración de las células germinales a las gónadas. Presentación de caso: lactante con pulmón blanco unilateral, discretas manifestaciones catarrales y diagnóstico inicial de neumonía extensa. La persistencia del cuadro radiológico motivó alta sospecha clínica de etiología subyacente no infecciosa. Se realizó tomografía computarizada multicorte durante su ingreso, que mostró imágenes sugestivas de tumor mediastínico. Fue intervenido quirúrgicamente con diagnóstico histológico de teratoma mediastinal maduro. Conclusiones: el teratoma mediastinal constituye una enfermedad poco frecuente con clínica inespecífica. Suelen presentarse como neumonía de lenta resolución o persistente, con signos no concluyentes en la radiografía pulmonar. Su tratamiento es quirúrgico; otros pilares terapéuticos son evaluados en el contexto anatomopatológico. Las variedades de peor pronóstico debutan en el primer año de vida; excepción relevante el caso clínico presentado.

ABSTRACT Introduction: teratoma is a tumor that originates from germ cells and it is constituted by different tissues derived from one or several embryonic layers. Mediastinal teratomas arise as a consequence of an embryogenic error during the migration of germ cells to the gonads. Case report: infant with unilateral white lung, discrete catarrhal manifestations and initial diagnosis of extensive pneumonia. The persistence of the radiological picture led to high clinical suspicion of non-infectious underlying etiology. Multislice computed tomography was performed during his admission, which showed images suggestive of mediastinal tumor. He underwent surgery with histological diagnosis of mature mediastinal teratoma. Conclusions: mediastinal teratoma is a rare entity with non-specific clinical features. They usually present as slow-resolution or persistent pneumonia, with inconclusive signs in pulmonary radiography. Its treatment is eminently surgical; other therapeutic pillars are evaluated in the pathologic context. The varieties with the worst prognosis have their onset in the first year of life; the clinical case presented is a significant exception.

[Perceptions of family doctors, pulmonologists and allergists on the approach to patients with chronic cough. Results of an anonymous survey]. / Percepciones de médicos de familia, neumólogos y alergólogos sobre el abordaje de los pacientes con tos crónica. Resultados de una encuesta anónima.

OBJECTIVE: To understand the perception of family doctors, pulmonologists and allergists about the current approach to chronic cough and its impact on patients' quality of life. MATERIAL AND METHODS: Cross-sectional and anonymous survey disseminated through the scientific societies SEAIC, SEMERGEN, semFYC, SEMG and SEPAR. The participants were 620 family doctors, 92 pulmonologists and 62 allergists. A descriptive analysis of the answers was conducted. Response percentages, medians and interquartile intervals were presented. The differences in the percentages between specialties were evaluated with the chi-square. RESULTS: Only half of the respondents chose a duration greater than 8 weeks as a criterion for diagnosing chronic cough, and less than half considered refractory/unexplained chronic cough a disease in itself. Family doctors perceived that chronic cough had less impact on patients than did pulmonologists or allergists. After a diagnosis of refractory/unexplained chronic cough, all 3specialties considered the most common approach to be to initiate treatment and to do the follow-up of the patient themselves. Most stated that they had no protocols for managing chronic cough, and more than 90% considered these to be necessary. CONCLUSIONS: The management of patients with chronic cough by family doctors, pulmonologists or allergists seems to be heterogeneous. There is a need for protocols that standardise diagnosis, referral and treatment criteria to optimise patients' management and reduce the impact of chronic cough.

Nivel de adhesión y prevalencia a inhaladores en pacientes ambulatorios con Asma y Enfermedad Pulmonar Obstructiva Crónica / Level of inhaler adhesion and prevalence in outpatients with Asthma and Chronic Obstructive Pulmonary Disease

INTRODUCCIÓN. Para el tratamiento farmacoterapéutico de enfermedades respi-ratorias, el uso de herramientas para abordar la vía inhalatoria es de elección por su mayor eficacia y menos efectos secundarios; registrar su adhesión y prevalencia es importante. OBJETIVO. Determinar el nivel y la prevalencia de adhesión al uso de inhaladores en pacientes con Asma y Enfermedad Pulmonar Obstructiva Cróni-ca. MATERIALES Y MÉTODOS. Estudio analítico transversal. Población de 215 y muestra de 121 Historias Clínicas. Se aplicó el Test de Adhesión a Inhaladores, que consistió en dos cuestionarios complementarios: el de 10 ítems, que valoró el nivel de adhesión, y el de 12 que identificó el tipo de incumplimiento en pacientes de Consulta Externa de la Unidad Técnica de Neumología del Hospital de Especialidades Carlos Andrade Marín, periodo julio 2018 - enero 2019. La tabulación y análisis de datos se realizó con el programa Excel. RESULTADOS. La prevalencia de mala adhesión en asmáticos fue de 83,33% y en Enfermedad Pulmonar Obstructiva Crónica 13,33%. En cuanto al sexo, la prevalencia de mala adhesión fue de 15,28% en hombres y de 40,82% en mujeres, con una p<0,05. No se encontró diferencia significativa respecto a los niveles de instrucción. CONCLUSIÓN. La prevalencia de mala adhesión al uso de inhaladores en pacientes con Asma y Enfermedad Pulmonar Obstructiva Crónica fue alta sobre todo en los asmáticos.

INTRODUCTION. For respiratory diseases and their pharmacotherapeutic treatment, the use of tools to address the inhalation route is chosen due to its greater efficacy and fewer secondary effects; then record the adherence and prevalence is important. OBJECTIVE. To determine both level and prevalence of adherence to the use of inhalers in patients with Asthma and Chronic Obstructive Pulmonary Disease. MATE-RIALS AND METHODS. Cross-sectional analytical study. Population of 215 and sam-ple of 121 patients. The Inhaler Adherence Test was applied, which consisted of two complementary questionnaires: a 10-item questionnaire, which assessed the level of adherence, and a 12-item questionnaire that identified the type of non-compliance in patients of the Pneumology Technical Unit of the Hospital de Especialidades Carlos Andrade Marín, period July 2018 - January 2019. The tabulation and data analysis was performed with Microsoft Excel program. RESULTS. The prevalence of poor ad-herence in asthmatics was 83.33% and in Chronic Obstructive Pulmonary Disease was 13.3%. Regarding gender, the prevalence of poor adherence was 15.28% in men and 40.82% in women, with a p <0.05. No significant differences were found regarding the levels of instruction. CONCLUSION. The prevalence of poor adherence to the use of inhalers in patients with Asthma and Chronic Obstructive Pulmonary Disease was high, especially in asthmatics

Health Outcomes: Towards the Accreditation of Respiratory Medicine Departments. / Resultados de salud: hacia la acreditación de los servicios de neumología.

National health systems must ensure compliance with conditions such as equity, efficiency, quality, and transparency. Since it is the right of society to know the health outcomes of its healthcare system, our aim was to develop a proposal for the accreditation of respiratory medicine departments in terms of care, teaching, and research, measuring health outcomes using quality of care indicators. The management tools proposed in this article should be implemented to improve outcomes and help us achieve our objectives. Promoting accreditation can serve as a stimulus to improve clinical management and enable professionals to take on greater leadership roles and take action to improve outcomes in patient care.

Radiological management and follow-up of post-COVID-19 patients. / Manejo y seguimiento radiológico del paciente post-COVID-19.

Most of the patients who overcome the SARS-CoV-2 infection do not present complications and do not require a specific follow-up, but a significant proportion (especially those with moderate / severe clinical forms of the disease) require clinicalradiological follow-up. Although there are hardly any references or clinical guidelines regarding the long-term follow-up of post-COVID-19 patients, radiological exams are being performed and monographic surveillance consultations are being set up in most of the hospitals to meet their needs. The purpose of this work is to share our experience in the management of the post-COVID-19 patient in two institutions thathave had a high incidence of COVID-19 and to propose general follow-uprecommendations from a clinical and radiological perspective.

Health outcomes: Towards the accreditation of respiratory medicine departments.

National health systems must ensure compliance with conditions such as equity, efficiency, quality, and transparency. Since it is the right of society to know the health outcomes of its healthcare system, our aim was to develop a proposal for the accreditation of respiratory medicine departments in terms of care, teaching, and research, measuring health outcomes using quality of care indicators. The management tools proposed in this article should be implemented to improve outcomes and help us achieve our objectives. Promoting accreditation can serve as a stimulus to improve clinical management and enable professionals to take on greater leadership roles and take action to improve outcomes in patient care.

Eficacia y seguridad de la mascarilla laríngea Protector (R) en procedimientos respiratorios invasivos / Efficacy and safety of the Protector (R) laryngeal mask in invasive respiratory procedures

Objetivos: Las pruebas respiratorias invasivas pueden ser realizadas bajo sedación profunda o preferentemente bajo anestesia general para facilitar su rea- lización y evitar complicaciones. Dichas pruebas requieren del manejo compartido de la vía aérea junto al neumólogo, por lo que tubos endotraqueales de gran calibre será necesarios para garantizar la ventilación. Una alternativa a la intubación sería la colocación de una mascarilla laríngea (ML). Pocos estudios recogen la realización de dichas pruebas con ML y no existe ningún estudio en el que se haya realizado con la ML Protector®. Esta ML presenta un gran canal calibre interno y la suficiente flexibilidad para poder realizarla reduciendo los riesgos de intubación. El objetivo de este estudio es demostrar la seguridad de la mascarilla laríngea Protector® para la realización de pruebas respiratorias invasivas.Metodología: Se reclutaron 55 pacientes consecutivos que fueron sometidos a pruebas respiratorias invasivas con la mascarilla laríngea Protector®. Resultados: La tasa de éxito con la ML Protector® ha sido del 92 % sin presentar complicaciones. La ventilación es garantizada con menores presiones pico que con un tubo endotraqueal, ningún paciente ha referido dolor de garganta y todos los pacientes fueron dados de alta como máximo a las 4 horas tras el procedimiento.Conclusiones: La realización de pruebas respiratorias invasivas con ML Protector® es seguro reduciendo las complicaciones asociadas a intubaciones con tubos de gran calibre y reduciendo las presiones para asegurar su ventilación. (AU)

Objective: Invasive respiratory tests can be performed under deep sedation or preferably under general anesthesia to facilitate their performance and avoid complications. These procedures require shared management of the airway with the pulmonologist, so large-caliber endotracheal tubes will be necessary to guarantee ventilation. An alternative to intubation would be the placement of a laryngeal mask. Few studies record the performance of such tests with LM and there are no studies in which it has been performed with LM Protector®. This LM presents a large internal caliber canal and sufficient flexibility to perform it, reducing the risks of intubation. The objective of this study is to demonstrate the safety of the Protector® laryngeal mask for invasive respiratory procedures. Method: Fifty-five consecutive patients who underwent invasive respiratory procedures with the Protector® laryngeal mask were recruited.Results: The success rate with the LM Protector has been 92 % without complications. Ventilation is guaranteed with lower peak pressures, no patient has reported a sore throat and all patients were discharged at most 4 hours after the procedure.Conclusions: Performing ventilatory respiratory procedures with LM Protector® is safe, reducing the complications associated with large-caliber tubes intubation. (AU)

Indicadores de calidad para unidades de cuidados intensivos respiratorios / Quality indicators for respiratory intensive care units / Indicadores de qualidade para as unidades de terapia intensiva respiratórias

Resumen: Introducción: Existen indicadores de calidad tanto generales como específicos en medicina crítica. Los indicadores para procesos propios de unidades de cuidados intensivos respiratorios (UCIRs) son necesarios. Material y métodos: Un grupo de trabajo de las UCIRs de los servicios de tórax de los principales hospitales de tercer y cuarto nivel de atención sanitaria en México, siguiendo la metodología de los grupos de trabajo de la Sociedad Española de Medicina Intensiva, Crítica y Unidades Coronarias y la Fundación Avedis-Donabedian, identificó aspectos relevantes del proceso del cuidado con relación a volumen, riesgo y complejidad, recabando información de 10 años de actividad asistencial para ser correlacionados y finalmente diseñar indicadores. Resultados: Con información de 2,776 pacientes atendidos del 1o de noviembre de 2009 al 1o de noviembre de 2019, se delimitó el campo de actuación con aspectos importantes como broncoscopia, neumonía, paciente inmunocomprometido, hemoptisis masiva, embolización de arterias bronquiales, cirugía de resección segmentaria/lobar o pulmonar, pleurocentesis y ultrasonido fueron identificados y correlacionados en consenso por el grupo de expertos, llevando al diseño de cuatro indicadores. Conclusiones: Este es el primer reporte de desarrollo de indicadores de calidad para UCIRs de servicios de tórax que servirán para la mejora de la calidad en este tipo de unidades.

Abstract: Introduction: There are both general and specific quality indicators in critical care medicine. Indicators for respiratory intensive care units (RICUs) processes are needed. Material and methods: Following the methodology of the working groups of the Spanish Society of Intensive, Critical Care and Coronary Units and the Avedis-Donabedian Foundation, a working group of the RICUs belonging to departments of chest medicine of the main hospitals of third and fourth level of care in Mexico identified relevant aspects of the care process in relation to volume, risk and complexity, collecting information from ten years of clinical activity to be correlated and finally to design indicators. Results: Delimitation of the field of action was made accounting with information on 2,776 patients treated from November 1, 2009 to November 1, 2019. Important aspects such as bronchoscopy, pneumonia, immunocompromised patient, massive hemoptysis, bronchial artery embolization, segmental/lobar or pulmonary resection surgery, thoracentesis and ultrasound were identified and correlated in consensus by the group of experts leading to the design of four indicators. Conclusions: This is the first report on the development of quality indicators for RICUs belonging to departments of chest medicine that will serve to improve quality in this type of units.

Resumo: Introdução: Existen indicadores de qualidade tanto gerais como específicos em medicina crítica. São necessários os indicadores para procesos própios das unidades de terapias intensivas respiratórias (UTIRs). Material e métodos: Um grupo de trabalho das UTIRs dos serviço de tórax dos principais hospitais de tercero e quarto níveis de atenção sanitária no México, seguindo a metodologia dos grupos de trabalho da Sociedade Espanhola de Terapia Intensiva, Crítica e Unidades Coronárias e a Fundação Avedis-Donabedian, identificou aspectos relevantes do processo de cuidado com relação ao volume, risco e complexidade, reunindo informações de 10 anos de atividade assistencial para ser correlacionada e, finalmente, desenhar indicadores. Resultados: Com informações de 2,776 pacientes atendidos de 1o de novembro de 2009 a 1o de novembro de 2019, o campo de atuação foi definido com aspectos importantes como broncoscopia, pneumonia, paciente imunocomprometido, hemoptise maciça, embolização de artérias brônquicas, cirurgia de ressecção segmentar/lobar ou pulmonar, pleurocentese e ultrassom foram identificados e correlacionados em consenso pelo grupo de especialistas, resultando no desenho de quatro indicadores. Conclusão: Este é o primeiro relatório de desenvolvimento de indicadores de qualidade para UTIRs do serviço de tórax que servirão para melhorar a qualidade neste tipo de unidade.

Manejo de la bronquiolitis aguda en el servicio de neumología pediátrica de Pinar del Río / Management of acute bronchiolitis in the pediatric pulmonology service in Pinar del Río

RESUMEN Introducción: la bronquiolitis aguda es la infección de vías respiratorias inferiores más frecuente en niños menores de un año, y supone el 18 % de todas las hospitalizaciones pediátricas. Objetivo: caracterizar el manejo de la bronquiolitis aguda en los pacientes ingresados en el servicio de neumología del Hospital Pediátrico Provincial Docente "Pepe Portilla" durante el año 2019. Métodos: se realizó un estudio observacional, descriptivo y de corte transversal. El universo estuvo constituido por los 612 pacientes con diagnóstico de bronquiolitis y la muestra fue de 482 pacientes. Resultados: predominaron los pacientes ingresados por cuadros ligeros de bronquiolitis (75,9 %), con estadía hospitalaria promedio menor de cinco días. Se realizaron hemograma, eritrosedimentación y radiografía de tórax en el 100 % de los pacientes, con bajo porcentaje de positividad. La ecografía de precordio se reportó en el 15,6 % por auscultación transitoria de soplos cardíacos. La oxigenoterapia fue prescrita en el 98,9 % de los casos, sin evidencia clínica de hipoxemia. Conclusiones: existió un exceso en la indicación de exámenes complementarios y prescripción de medicamentos. Se encontró prescripción irracional de broncodilatadores inhalados, esteroides sistémicos y antihistamínicos. Existe dependencia de los medios diagnósticos, lo cual refleja la necesidad de un mayor empleo del método clínico.

ABSTRACT Introduction: acute bronchiolitis is the most frequent lower respiratory tract infection in children under one year of old and accounts for 18% of all pediatric hospitalizations. Objective: to characterize the management of acute bronchiolitis in patients admitted to the pulmonology service at Pepe Portilla Pediatric Teaching Hospital during 2019. Methods: an observational, descriptive and cross-sectional study was carried out. The target group comprised 612 patients diagnosed with bronchiolitis and the sample included 482 patients who met the inclusion criteria: moderate, mild cases with risk factors and clinical history with complete data. Descriptive statistical techniques were applied to process the information collected. Results: patients were admitted for mild bronchiolitis (75.9%), with an average stay of less than 5 days. Complete Blood Count (CBC), erythrocyte sedimentation and chest radiography was performed in 100% of patients, with low percentage of positivity. Prechordal ultrasound was reported in 15.6% by transitory auscultation of cardiac murmurs. Oxygen therapy was prescribed in 98.9% of cases, with no clinical evidence of hypoxemia. Conclusions: there was an excess in the indication of complementary examinations and medication prescription. There was found an irrational prescription of inhaled bronchodilators, systemic steroids and antihistamines. There is dependence on diagnostic means, which reflects the need for a better application of the clinical method.

Variación de los biomarcadores tumorales en pacientes con enfermedades respiratorias crónicas / Variation of tumoral biomarkers in patients with chronic respiratory diseases

Introducción: Los biomarcadores son sustancias biológicas o bioquímicas que aparecen como respuesta del organismo ante ciertos tipos de tumores y que reflejan la etapa y el grado de estos. Objetivo: Determinar la asociación de los marcadores tumorales con los procesos respiratorios crónicos. Métodos: Se realizó un estudio descriptivo y transversal de 306 pacientes diagnosticados con enfermedades respiratorias crónicas, atendidos en las consultas comunitarias de neumología de la provincia de Santiago de Cuba, de enero del 2014 a diciembre del 2018. Resultados: En la serie predominaron el sexo masculino y las edades de 60 a 69 años, así como las enfermedades intersticiales, la bronquitis crónica y la enfermedad pulmonar obstructiva crónica. De igual modo, resultaron importantes los estudios radiológicos para la detección de procesos neoplásicos, sobre todo el empleo de la tomografía axial computarizada. Por otra parte, los marcadores que presentaron valores alterados fueron el CYFRA 21.1 y el CA 72.4, de manera que se demostró su asociación con los procesos respiratorios crónicos. Conclusiones: Los biomarcadores tumorales son una herramienta útil en el seguimiento de pacientes con neoplasias malignas, pero también muestran valores alterados ante la presencia de varias enfermedades respiratorias crónicas sin que ello represente la existencia de un proceso maligno.

Introduction: Biomarkers are biological or biochemical substances which emerge as a response of the organism on certain types of tumors and which reflect the stage or degree of them. Objective: To determine the association of tumoral markers with the chronic respiratory events. Methods: A descriptive and cross-sectional study of 306 patients diagnosed with chonic respiratory diseases and assisted at the Pneumology community outpàtients from Santiago de Cuba province was carried out from January, 2014 to December, 2018. Results: Male sex and ages between 60 o 69 years as well as interstitial diseases, chronic bronchitis and the chronic obstructive pulmonary disease predominated in the series. Likewise, radiological studies were also important for detecting neoplasic processes, mainly with the use of the axial computerized tomography. On the other side, markers presenting altered values were the CYFRA 21.1 y el CA 72.4, so that its association with the chronic respiratory processes. Conclusions: Tumoral biomarkers are an usefull tool in the follow-up of patients with malignant neoplasies, but also they show altered values in the presence of different chronic respiratory diseases, which doesn´t mean there is a malignant process.

Organization of Tuberculosis Control in Spain: Evaluation of a Strategy Aimed at Promoting the Accreditation of Tuberculosis Units. / Organización del control de la tuberculosis en España: evaluación de una estrategia dirigida a fomentar la acreditación de unidades de tuberculosis.

INTRODUCTION: Well-coordinated multidisciplinary teams are essential for better tuberculosis (TB) control. Our objective was to evaluate the impact of Spanish Society of Pneumology (SEPAR) accreditation of TB Units (TBU) and to determine differences between the accredited and non-accredited centers. DESIGN: Observational descriptive study based on a self-administered survey from October 2014 to February 2018 completed by 139 heads of respiratory medicine departments collected by SEPAR, before and after TBU accreditation. VARIABLES: demographic, epidemiological and contact tracing (CT) variables, among others. ANALYSIS: basic descriptive analysis, and calculation of medians for continuous variables and proportions for categorical variables. The variables were compared using the Chi-squared test and logistic regression. RESULTS: The response rate was 54.7% and 43.2% in the pre- and post-TBU accreditation period, respectively. No differences were observed in the care and coordination variables between the pre- and post-accreditation survey, nor in the organization when only accredited centers were analyzed. When we compared the accredited and non-accredited centers, significant differences were detected in the collection of the final conclusion, management of resistance, coordination with other departments, contact tracing, and directly observed treatment. CONCLUSIONS: The approach of different professionals with regard to TB has been addressed. Positive aspects and areas for improvement have been detected, and better results were observed in the accredited versus non-accredited centers. A closer supervision of TBUs is necessary to improve their effectiveness.

Psychometric properties of the questionnaire on threat perception of chronic illnesses in pediatric patients / Propriedades psicométricas do questionário de percepção da ameaça da doença crônica em pediatria / Propiedades psicométricas del cuestionario de percepción de amenaza de la enfermedad crónica en pediatría

Objective: the objective of the study was to assess the psychometric properties of the Brief Illness Perception Questionnaire in a sample of adolescents with chronic endocrine or pneumological conditions and to analyze the dimensionality and reduce the scale elaborating scales by sex and medical diagnosis. Method: we evaluated 510 patients aged 9-16 years using the Brief Illness Perception Questionnaire and the Hospital Anxiety and Depression Scale. We carried out tests of reliability, construct and criterion validity and a comparison of means based on the diagnosis and socio-demographic variables. The reliability and validity analyses showed adequate psychometric properties for this scale, with better results obtained for a single dimension after eliminating 3 items. Results: adolescents with type 1 diabetes and girls were found to have an increased threat perception of their illness. Anxiety/depression was positively associated with the perception of illness. Conclusion: this questionnaire is a useful and practical tool for evaluating adjustment to illness in pediatric patients.

Objetivo: o objetivo do estudo foi avaliar as propriedades psicométricas do Questionário de Percepção de Doenças Versão Breve em uma amostra de adolescentes com condições endócrinas ou pneumológicas crônicas. Analisar a dimensionalidade e reduzir a escala elaborando baremas por sexo e diagnóstico médico. Método: avaliamos 510 pacientes com idades entre 9 e 16 anos usando o Questionário de Percepção de Doenças Versão Breve e a Escala Hospitalar de Ansiedade e Depressão. Foram realizados testes de confiabilidade, validade do construto, validade de critério e comparação de médias segundo o diagnóstico e as variáveis sociodemográficas. As análises de confiabilidade e validade mostraram propriedades psicométricas adequadas para essa escala, obtendo melhores resultados para uma única dimensão após a exclusão de 3 itens. Resultados: observou-se que adolescentes com diabetes tipo 1 e meninas demonstraram maior percepção da ameaça da doença. A ansiedade/depressão associou-se positivamente à percepção da doença. Conclusão: este questionário é uma ferramenta útil e prática para avaliar o ajuste à doença em pacientes pediátricos.

Objetivo: el objetivo del estudio ha sido valorar las propiedades psicométricas del Cuestionario Breve de Percepción de la Enfermedad en una muestra de adolescentes con condiciones crónicas endocrinas o neumológicas. Analizar la dimensionalidad y reducir la escala elaborando baremos por sexo y diagnóstico médico. Método: evaluamos 510 pacientes de entre 9-16 años mediante el Cuestionario Breve de Percepción de la Enfermedad y la Escala Hospitalaria de Ansiedad y Depresión. Realizamos pruebas de fiabilidad, validez de constructo y criterial y comparación de medias en función del diagnóstico y variables sociodemográficas. Los análisis de fiabilidad y validez mostraron adecuadas propiedades psicométricas para esta escala, obteniendo mejores resultados para una única dimensión después de eliminar 3 ítems. Resultados: se observó que los adolescentes con diabetes tipo 1 y las niñas mostraban mayor percepción de amenaza de la enfermedad. La ansiedad/depresión se asociaron positivamente con la percepción de enfermedad. Conclusión: este cuestionario resulta una herramienta útil y práctica, con la que evaluar el ajuste a la enfermedad en pacientes pediátricos.

Bronquiolitis Obliterante como secuela de infección por Adenovirus. Presentación de caso, Hospital Infantil Dr. Robert Reid Cabral / Bronchiolitis Obliterans as sequel of Adenovirus infection. Case report, Hospital Infantil Dr. Robert Reid Cabral

Los procesos pulmonares en menores de dos años son causados en su mayoría por agentes virales, los cuales, en gran parte, se resuelven sin complicaciones posteriores. Sin embargo, hay agentes causales que debemos tener presentes puesto que pueden dejar secuelas importantes a nivel pulmonar. A continuación, presentamos un caso de bronquiolitis obliterante como secuela de infección por adenovirus

Pulmonary processes in children under two years are mostly caused by viral agents, which are largely resolved without further complications, however there are causal agents that we must keep in mind that can leave important sequelae at the lungs. We present a case of Bronchiolitis Obliterans as sequel of Adenovirus infection